OFFICIAL BIBLIOGRAPHY
- 1. Bishoff, S.C. et al., 2022, “ESPEN Guideline on Clinical Nutrition in Inflammatory Bowel Disease”
- 2. Bishoff, S.C. et al., 2017, “ESPEN Practical Guideline: Clinical Nutrition in Chronic Inflammatory Bowel Disease (IBD)”
- 3. Magavi, P.R. et al., 2022, “Incorporating Nutrition-Based Strategies into IBD Treatment”
- 4. Chouraki, V. et al., 2011, “The changing pattern of Crohn’s disease incidence in northern France: a continuing increase in the 10- to 19-year-old age group (1988–2007)”
- 5. AMICI Italia “Crohn’s Disease”
- 6. Singh, A. et al., 2022, “Evaluation of Nutritional Characteristics Reveals a Similar Prevalence of ‘ Malnutrition ’ in Patients with Ulcerative Colitis and Crohn’s Disease”
- 7. ESPEN Fact Sheets “Disease-Related Malnutrition s (DRMs) – A Neglected Threat to Every Patient: Nutritional Care Matters”
- 8. Dhaliwal, A. et al., 2021, “Sarcopenia in Inflammatory Bowel Disease: A Narrative Overview”
- 9. Burish, J. et al., 2018 “Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study”
- 10. Ministry of Health, 2025 “Guidelines on Food for special medical purposes (FSMPs) – Revised July 15, 2025”
- 11. SINPE, SIGENP “The Bid Specifications for the Enteral Nutrition Procurement Bid”
- 12. Rinninella, E. et al., 2023, “Botanicals in Human Nutrition: Focus on the Effects of Bioactive Food-Derived Compounds on the Gut Microbiota in Gastrointestinal Inflammatory Diseases”
- 13. Loy, L. et al., 2024, “Dietary Fiber in Inflammatory Bowel Disease: Are We Ready to Change the Paradigm?”
- 14. Feldheiser, A. et al., 2015, “Enhanced Recovery After Surgery (ERAS) for Gastrointestinal Surgery, Part 2: Consensus Statement for Anesthesia Practice”
- 15. Hoshimoto, A. et al., 2002, “Caprylic acid and medium-chain triglycerides inhibit IL-8 gene transcription in Caco-2 cells: a comparison with the potent histone deacetylase inhibitor trichostatin A”
- 16. Hashash, J.G. et al., 2024, “AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review”
- 17. Massironi, S. et al., 2023, “Inflammation and Malnutrition in Inflammatory Bowel Disease”
- 18. Di Stefano, M. et al., 2024 “T.11.1: Micronutrient Nutritional Deficiencies in Patients with Inflammatory Bowel Disease in Remission Following Long-Term Biologic Treatment”
- 19. ESPEN Fact Sheets “GLIM Criteria for the Diagnosis of malnutrition – A Consensus Report from the Global Clinical Nutrition Community”
- 20. Lombardy Region, 2024 “Appendix A – Resolution XII/1812”
- 21. Pennings, B. et al., 2011, “Whey protein stimulates postprandial muscle protein accretion more effectively than casein and casein hydrolysate do in older men”
- 22. AMICI Italia “Ulcerative Colitis”
- 23. Fazion, C., 2024 “Chronic Intestinal Diseases: Symptoms Are Out of Control in Half of All Cases”
- 24. Panorama della Sanità, 2022: “Crohn’s Disease and Ulcerative Colitis: The Number of Patients Is Expected to Double by 2030”
- 25. Ministry of Health, 2022 “Conference for World Chronic Intestinal Diseases Day”
- 26. Cárdenas, D. et al., 2022, “Nutritional Care Is a Human Right: Translating Principles into Clinical Practice”
- 27. Lombardy Region, 2024 “Implementation of the nutritional screening program in Regional Health Service (SSR) facilities and at home”
- 28. ASPEN, ESPEN, FELANPE, 2022, “The International Declaration on the Human Right to Nutritional Care”
- 29. ESPEN Fact Sheets, 2022, “Nutritional Care is a Human Right – The International Declaration on the Human Right to Nutritional Care (‘Vienna Declaration’)”
- 30. Lionhealth “ LH ViolaTechnical Data Sheet”
- 31. Saibeni, S. et al., 2023, “Nutritional Care at Centers Treating Patients with Inflammatory Bowel Disease: A Nationwide Survey in Italy”
- 32. Bezzio, C. et al., 2024, “Prevalence, Risk Factors, and Association with Clinical Outcomes of Malnutrition , and Sarcopenia in Inflammatory Bowel Disease: A Prospective Study”
- 33. Cammarota, G. et al., 2024 “Review Article: Green Management of IBD—New Paradigms for an Eco-Friendly Approach”
- 34. AMICI Italia & SINPE, 2024 “Malnutrition in Chronic Inflammatory Bowel Diseases (IBD): Preliminary Results of the 2024 AMICI Italia Survey”
- 35. Falcone, E. et al., 2024 “Malnutrition and Chronic Inflammatory Bowel Diseases (IBD): The Need for a National Regulatory Framework to Ensure Equity in Nutritional Care”
- 36. Fiorindi, C. et al., 2020, “GLIM Criteria for the Malnutrition s in Surgical IBD Patients: A Pilot Study”
- 37. Casanova, M.J. et al., 2017, “Prevalence of Malnutrition , and Nutritional Characteristics of Patients With Inflammatory Bowel Disease”
- 38. Elia, M. et al., 2016, “A systematic review of the cost and cost-effectiveness of using standard oral nutritional supplements in community and nursing home settings”
- 39. Pradelli, L. et al., 2022, “Prevalence and economic cost of malnutrition in Italy: a systematic review and meta-analysis by the Italian Society of Artificial Nutrition and Metabolism (SINPE)”
- 40. NICE, 2017, “Nutrition Support for Adults: Oral Nutrition Support, Enteral Tube Feeding, and Parenteral Nutrition (CG32)”
- 41. Philipson, T. et al., 2013, “OP015 IMPACT OF ORAL NUTRITIONAL SUPPLEMENTATION ON HOSPITAL OUTCOMES”
- 42. Brennan, G.T. et al., 2018, “Does preoperative enteral or parenteral nutrition reduce postoperative complications in patients with Crohn’s disease?”
- 43. Niccolai, M. “The ESG Dimension in Bidding: The Green and Social Approach in Public Procurement. The Role and Experience of Central Purchasing Agencies”
- 44. Ministry of Health, 2024, “Dietary Supplements and Ministerial Guidelines (LGM)”
- 45. European Union, 2006 “Regulation (EC) No. 1924/2006—Nutrition and Health Claims Made on Foods”
- 46. Ansell, J. et al., 2008, “Pharmacology and Management of Vitamin K Antagonists”
- 47. Forbes, A. et al., 2017, “ESPEN Guideline: Clinical Nutrition in Inflammatory Bowel Disease”
- 48. Barazzoni, R. et al., 2022, “Guidance for the Assessment of the Muscle Mass Phenotypic Criterion for the Global Leadership Initiative on Malnutrition s (GLIM) Diagnosis of malnutrition”
- 49. European Union, 2013 “Regulation (EU) No. 609/2013—Foods intended for infants and young children, Food for special medical purposes , and meal-replacement products for weight management”
- 50. European Union, 2015 “Delegated Regulation (EU) 2016/128—Specific Requirements Regarding Composition and Information for Foods Intended for Special Medical Purposes”
- 51. Ministry of Health, 2018, “Guidelines on Studies Conducted to Evaluate the Safety and Properties of Food Products”
- 52. Muscaritoli, M. et al., 2017, “Prevalence of malnutrition in patients at their first medical oncology visit: the PreMiO study”
- 53. Muscaritoli, M. et al., 2021, “ESPEN Practical Guidelines: Clinical Nutrition in Cancer”
- 54. Pedrazzoli, P. et al., 2024 “NUTRITIONAL SUPPORT FOR PATIENTS UNDERGOING ACTIVE THERAPY”
- 55. Elia, M. et al., 2018, “Cost-effectiveness of oral nutritional supplements in older, malnourished nursing home residents”
- 56. ANAC – National Anti-Corruption Authority, 2017 “Guideline No. 8 – Use of Negotiated Procedures Without Prior Publication of a Request for Proposals in the Case of Supplies and Services Deemed Non-Interchangeable”
- 57. Nasim, H.E. et al., 2023, “The Role of TGF-β, Activin, and Follistatin in Inflammatory Bowel Disease”
- 58. Barberio, B. et al., 2025, “Dietary Interventions and Oral Nutritional Supplementation in Inflammatory Bowel Disease: Current Evidence and Future Directions”
- 59. Fiorino, G. et al., 2025 “Adaptation of the European Crohn’s Colitis Organization’s quality of care standards to Italy: The Italian Group for the Study of Inflammatory Bowel Disease Consensus”
- 60. Office of the Prime Minister, 2017, “First Update to the Decree of the Prime Minister of January 12, 2017, on Essential Levels of Care”
- 61. 47th ESPEN Congress 2025, 2025 “Malnutrition-Related Healthcare Costs in Hospitalized Patients with Inflammatory Bowel Disease: A Nationwide Real-World Data Analysis”
- 62. Lidoriki, I. et al., 2020, “Oral Nutritional Supplementation Following Upper Gastrointestinal Cancer Surgery: A Prospective Analysis Exploring Potential Barriers to Compliance”
- 63. BAPEN, 2003, “The ‘MUST’ Report — Nutritional Screening of Adults: A Multidisciplinary Responsibility”
- 64. AIOM, 2025, “Cancer Statistics in Italy 2025”
- 65. UNIAMO Federation, 2024, “Rare Diseases: What Are They?”
- 66. Ministry of Health, 2025 “World Alzheimer’s Day: The Ministry’s Commitment to Patients and Families”
- 67. Rozzi, A., 2024 “World COPD Day 2024: The Importance of Spirometry”
- 68. Huang, C. et al., 2025, “The Efficacy of Infliximab Combined with Partial Enteral Nutrition in the Treatment of Crohn’s Disease: A Cohort Study”
- 69. WHO Regional Office for Europe, 2023, “Disease-Related Malnutrition: A Time for Action”
- 70. Grand View Research, 2024, “Europe Medical Foods Market Size and Share Report, 2030”
- 71. Deng, M. et al., 2023, “Global Prevalence of Malnutrition in Patients with Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis”
- 72. BAPEN / Malnutrition Advisory Group (MAG), 2010, “’MUST’: Malnutrition Universal Screening Tool”
- 73. Cruz-Jentoft, A. et al., 2019, “Sarcopenia: Revised European Consensus on Definition and Diagnosis”
- 74. Rare Diseases Observatory, 2024 “Chronic Inflammatory Bowel Diseases: 250,000 Patients in Italy”
- 75. AMICI Italia, 2026 “AMICI Italia 2026 Survey (unpublished data)”
- 76. Ministry of Health, 2025 “Explanatory Report: First Update to the Decree of the President of the Council of Ministers of January 12, 2017, on Essential Levels of Care”
- 77. Beaudart, C. et al., 2017, “Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis”
- 78. Beaudart, C. et al., 2023, “Sarcopenia and Health-Related Quality of Life: A Systematic Review and Meta-Analysis”
- 79. Calvez, V. et al., 2024, “Navigating the Intersection: Sarcopenia and Sarcopenic Obesity in Inflammatory Bowel Disease”
- 80. Feng, Y. et al., 2024, “Sarcopenia and Treatment Failure in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis”
- 81. Kuzuya, M. et al., 2025, “Guidelines for Nutritional Management of Sarcopenia and Frailty 2025”
- 82. Pozzi, L., 2026 “Nutritional Management of a Patient with Crohn’s Disease Following Ileocecal Resection and Severe Malnutrition”
- 83. Muscaritoli, M. et al., 2023, “The Impact of Nutritional Status at the First Medical Oncology Visit on Clinical Outcomes: The NUTRIONCO Study”
- 84. De Felice, F. et al., 2025, “Progress and Challenges in Integrating Nutritional Care into Oncology Practice: Results from a National Survey on Behalf of the NutriOnc Research Group”
- 85. Zhang, J. et al., 2025, “Global Epidemiological Characteristics of Malnutrition in Cancer Patients: A Comprehensive Meta-Analysis and Systematic Review”
- 86. Muscaritoli, M. et al., 2021, “ESPEN Practical Guideline: Clinical Nutrition in Cancer”
- 87. Arends, J. et al., 2021, “Cancer Cachexia in Adult Patients: ESMO Clinical Practice Guidelines”
- 88. Elad, S. et al., 2020, “MASCC/ISOO Clinical Practice Guidelines for the Management of Mucositis Secondary to Cancer Therapy”
- 89. Pathak, S. et al., 2019, “A Randomized Controlled Trial to Evaluate the Role and Efficacy of Oral Glutamine in the Treatment of Chemoradiotherapy-Induced Oral Mucositis and Dysphagia in Patients with Oropharyngeal and Laryngeal Carcinoma”
- 90. Nan, D. et al., 2025, “Glutamine and Cancer: Metabolism, Immune Microenvironment, and Therapeutic Targets”
- 91. Agare, GI, et al., 2025, “Zinc Supplementation for Mitigating Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiotherapy and Chemoradiotherapy: A Systematic Review”
- 92. Raczyńska, A. et al., 2025, “The Impact of Immunomodulatory Components Used in Clinical Nutrition—A Narrative Review”
- 93. Elango, S. et al., 2018, “Selenium Influences Trace Element Homeostasis and Cancer Biomarkers in Patients with Squamous Cell Carcinoma Receiving Cancer-Killing Radiotherapy”
- 94. Yehia, R. et al., 2019 “L-Carnosine Protects Against Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients: A Perspective on Targeting the Nrf-2 and NF-κB Pathways”
- 95. Prakash, M.D. et al., 2021, “Anti-Cancer Effects of Carnosine—A Dipeptide Molecule”
- 96. García-Peris, P. et al., 2012 “Effect of a mixture of inulin and fructo-oligosaccharide on the intestinal microbiota of Lactobacillus and Bifidobacterium in patients receiving radiation therapy: a randomized, double-blind, placebo-controlled trial”
- 97. Pedrosa, LdF., et al., 2023, “Dietary Fiber as a Key Component of Colorectal Cancer Prevention and Adjuvant Therapy”
- 98. Asim, F. et al., 2023, “How do tumors outside the gastrointestinal tract respond to dietary fiber supplementation?”
- 99. Bellerba, F. et al., 2022, “Colorectal Cancer, Vitamin D, and the Microbiota: A Double-Blind Phase II Randomized Trial (ColoViD) in Patients with Colorectal Cancer”
- 100. Riantiningtyas, R.R., et al., 2026, “Oral Sensory Alterations and Their Influence on Food Preferences and Eating Difficulties in Oncology Patients: A Quantitative Descriptive Study”
- 101. Delsoglio, M. et al., 2025, “Use of high-protein oral nutritional supplements in patients with cancer reduces complications and length of hospital stay: a systematic review and meta-analysis”
- 102. Gascón-Ruiz, M. et al., 2022, “ Malnutrition , as Diagnosed According to GLIM Criteria, Predicts Complications and 6-Month Survival in Cancer Outpatients”
- 103. Scortichini, M. et al., 2026, “The Economic Burden of Disease-Related Malnutrition s in Inflammatory Bowel Disease: A Nationwide Study from Italy”
- 104. Morcom, CR, et al., 2025, “The biological mechanisms underpinning the nutritional and health-related consequences of mucositis in head and neck cancer—A review”
- 105. Pulito, C. et al., 2020 “Oral mucositis: the hidden side of cancer therapy”
- 106. Ministry of Health, 2017, “Guidelines on Nutritional Care for Cancer Patients”
- 107. Kiss, N. et al., 2026, “Guidelines for Nutrition in Adults with Head and Neck Cancer: The American Society for Parenteral and Enteral Nutrition”
- 108. García-Peris, P. et al., 2016, “Effect of inulin and fructo-oligosaccharides on the prevention of acute radiation enteritis in patients with gynecological cancer and their impact on quality of life: a randomized, double-blind, placebo-controlled trial”
- 109. ASPEN, 2023, “Indications for Enteral Nutrition in Patients with Oncological Diseases”
- 110. Su, L. et al., 2023 “The Effect of Early Oral Nutritional Supplements on Improving Nutritional Outcomes and Radiation-Induced Oral Mucositis in Patients with Nasopharyngeal Carcinoma Undergoing Concurrent Chemoradiotherapy”
- 111. Peng, TR, et al., 2021, “Effectiveness of glutamine in the management of oral mucositis in cancer patients: a meta-analysis of randomized controlled trials”
- 112. Posa, DK, et al., 2023, “Skeletal muscle analysis of cancer patients reveals a potential role for carnosine in muscle wasting”
- 113. Dalimunthe, A. et al., 2026, “Immunonutrients as Modulators of Inflammation, Barrier Integrity, and Immune Regulation: Toward Precision Nutrition”
- 114. Hu, J. et al., 2023, “Use of Dietary Fibers in Reducing the Risk of Several Types of Cancer: An Umbrella Review”
- 115. Fang, C. et al., 2025 “Novel Progress in the Application of the Small-Molecule Drug Carnosine for the Treatment of Several Diseases (Review)”
- 116. Anandhi, P. et al., 2020, “The Benefit of Zinc Sulfate in Oropharyngeal Mucositis during Hyperfractionated Accelerated Concomitant Boost Radiotherapy with Concurrent Cisplatin for Advanced-Stage Oropharyngeal and Hypopharyngeal Cancers”
- 117. De Haan, JJ. et al., 2021, “Self-reported changes in taste and smell and the acceptance of oral nutritional supplements with sensory-adapted flavors in cancer patients receiving systemic anticancer treatment”
- 118. Jukic, I. et al., 2021, “Carnosine: Small but Mighty—Prospects for Use as a Functional Ingredient in Functional Food Formulations”
- 119. Mishra, P. et al., 2025, “From Dysbiosis to Diagnosis: The Role of the Gut Microbiota in the Etiology and Management of Breast Cancer”
- 120. Lidoriki, I. et al., 2020, “Oral Nutritional Supplementation Following Upper Gastrointestinal Cancer Surgery: A Prospective Analysis Exploring Potential Barriers to Compliance”
- 121. Skrajnowska, D. et al., 2019, “Role of Zinc in the Immune System and Anti-Cancer Defense Mechanisms”
- 122. Cereda, E. et al., 2019, “Whey protein isolate supplementation improves body composition, muscle strength, and treatment tolerance in malnourished patients with advanced cancer undergoing chemotherapy”
- 123. Caccialanza, R. et al., 2026, “Nutrition in Oncology”
